Year: 2009
Type: article
Abstract: Modern drug discovery is increasingly in need of a novel paradigm to replace the classical blockbuster-based economic model of large pharmaceutical companies. Loss of patent protection, the rise in...
Source: Expert Review of Proteomics
DOI: 10.1586/epr.09.45
Authors: Pierre Escoubas, Glenn F King
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: bronze
Funder: University of Technology Sydney
OpenAlex ID: W2039949556
